✦ LIBER ✦

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

✍ Scribed by Wendy De Roock; Veerle De Vriendt; Nicola Normanno; Fortunato Ciardiello; Sabine Tejpar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined analysis of KRAS and PIK3CA mut

✍ Voutsina, Alexandra; Tzardi, Maria; Kalikaki, Aristea; Zafeiriou, Zafeiris; Papa 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

Implications for KRAS status and EGFR-ta

✍ Normanno, Nicola; Tejpar, Sabine; Morgillo, Floriana; De Luca, Antonella; Van Cu 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB

Effects of KRAS, BRAF, NRAS, and PIK3CA

✍ Wendy De Roock; Bart Claes; David Bernasconi; Jef De Schutter; Bart Biesmans; Ge 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 384 KB

Evaluation of the association of PIK3CA

✍ E. Razis; M. Bobos; V. Kotoula; A. G. Eleftheraki; H. P. Kalofonos; K. Pavlakis; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 288 KB

Frequency of KRAS, BRAF, and PIK3CA muta

✍ Mi Jung Kwon; Seung Eun Lee; So Young Kang; Yoon-La Choi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 650 KB

KRAS codon 61, 146 and BRAF mutations pr

✍ Loupakis, F; Ruzzo, A; Cremolini, C; Vincenzi, B; Salvatore, L; Santini, D; Masi 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 295 KB